Fortamet FDA Approval History
FDA Approved: Yes (Discontinued) (First approved April 28, 2004)
Brand name: Fortamet
Generic name: metformin
Dosage form: Extended-Release Tablets
Company: Andrx Corporation
Treatment for: Diabetes, Type 2
Marketing Status: Discontinued.
Fortamet (metformin) is an extended-release antihyperglycemic for the treatment of type 2 diabetes.
Development timeline for Fortamet
| Date | Article |
|---|---|
| Apr 28, 2004 | Approval FDA Approves Fortamet (metformin HCl) Extended-Release Tablets for Type 2 Diabetes |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
